Emerging Companies: Berkeley Resources Ltd (ASX:BKY)
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Overview: Berkeley Resources Limited ("Berkeley", the Company") is an Australian minerals company with uranium assets in Spain. The Company’s most advanced asset is the Salamanca Project, where indicated resources of 34.4million tonnes (mt) and inferred resources of 31mt have been delineated. We initiated coverage in Feb 2012 at $0.34/share with a ‘spec buy’ recommendation for its development potential. During Sep 2013 a Preliminary Feasibility Study(PFS) was completed into a 2.7million lb pa operation with 11-year mine life.
Catalysts: The recently completed Salamanca PFS highlighted globally attractive operating (<US$25/lb) and start-up capital costs (US$95.1m). The Project’s near-term development potential has also been supported by recent permitting advances, with the Environmental License received in Oct 2013 following a 24-month process. We expect satisfaction with final mining and processing regulations, and uranium market developments to drive interest in the Company.
Hurdles: Salamanca PFS indicates that project development requires a uranium price of US$65/lb, which is a significant premium to the current spot price of ~US$35/lb. Whilst the Company is well funded to complete Feasibility works, it remains reliant on external capital to advance project development.
Investment View: Berkeley offers speculative exposure to a recovery in uranium markets. We are attracted to management’s track record of delivering shareholder value, and Berkeley’s strong funding position. Its recently completed PFS highlights Salamanca as one of the world’s most compelling, independently held undeveloped uranium projects. In our view, current market pricing is constraining supply across the industry, and looming nuclear capacity additions in Asia have the potential to stimulate a recovery. Offering strong leverage to improving uranium markets, we maintain our ‘spec buy’ recommendation.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.